The following is a current list of our studies at the Asthma Research Center. All studies are open for enrollment, unless otherwise noted. The Asthma Research Center runs multiple studies and each study varies in duration and compensation is up to $1,630 for your time and effort. To see if you are eligible for any of our studies, please contact us.
|
Results 1 - 4 of 9 total studies
Page 1 of 3
1
2
3
>> next |
|
|
|
|
|
The purpose of this study is to find out how one’s genetic background influences the therapeutic response to salmeterol (Serevent®) for treatment of exercise-induced asthma. You may be eligible if you have asthma and are between the ages of 18-50 years. Participants will be seen by a medical doctor and receive study related testing and asthma medications at no cost. It involves 3-4 study visits over a 4-week period.
 more information on becoming a participant
|
|
|
The Asthma Research Center at Brigham and Women’s Hospital is recruiting asthmatics aged 18-75 who use Inhaled Corticosteroids (i.e. Flovent 220 or Advair 500/50) and at least one other asthma medication to control their symptoms. The research study involves 7 visits over an 18 weeks period and involves 4 infusions. The study’s purpose is to assess the safety and effectiveness of a new medication in the treatment of asthma.
more information on becoming a participant
|
|
|
Patients prescribed Advair®, Symbicort®, Salmeterol or Formoterol are randomized (like a flip of a coin) to receive therapy with inhaled corticosteroid along with either a long acting beta agonist or a long-acting anti-cholinergic to determine which group has better asthma control and if the asthma control is influenced by the kind of genes you have. This is 52-week study involving 4 study visits. Each visit lasts about an hour.
more information on becoming a participant
|
|
|
This research study will look at patients with moderate to severe persistent asthma. One group will receive standard treatment plus subcutaneous injections of XOLAIR for 80 weeks, while the other group will receive standard treatment plus placebo injections (contains no active medication) for 80 weeks. This study involves bronchoscopies. All subjects will receive their inhalers, like Advair, Flovent, and Albuterol, at no cost for the duration of the study.
more information on becoming a participant
|
|
 Return to top |
|
Results 1 - 4 of 9 total studies
Page 1 of 3
1
2
3
>> next |
|
|
